Formulation and In Vivo Evaluation of Self-Nanoemulsifying Granules for Oral Delivery of a Combination of Ezetimibe and Simvastatin

REFERENCES

• I. S. Ahmed, and H. A. Aboul-Einien. (2007). In vitro and in vivo evaluation of a fast- disintegrating lyophilized dry emulsion tablet containing griseofulvin. Eur. J. Pharm. Sci. 32:58–68.
   PubMed Web of Science ®Google Scholar
• A. Alvarez-Lueje, C. Valenzuela, J. A. Squella, and L. J. Núñez-Vergara. (2005). Stability study of simvastatin under hydrolytic conditions assessed by liquid chromatography. J AOAC Int. 88:1631–1636.
   PubMed Web of Science ®Google Scholar
• A. A. Ambike, K. R. Mahadik, and A. R. Paradkar. (2005). Spray-dried amorphous solid dispersions of Simvastatin, a low Tg drug: In vitro and in vivo evaluations. Pharm. Res. 22:990–998.
   PubMed Web of Science ®Google Scholar
• H. E. Bays, L. Ose, N. Fraser, D. L. Tribble, K. Quinto, R. Reyes, A. O Johnson-Levonas, A. Sapre, and S. R. Donahue. (2004). A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the Ezetimibe/Simvastatin tablet compared with Ezetimibe and Simvastatin monotherapy in patients with primary hypercholesterolemia. Clin. Ther. 26:1758–1773.
   PubMed Web of Science ®Google Scholar
• O. Chambin, C. Bellone, D. Champion, M. H. Rochat-Gonthier, and Y. Pourcelot. (2000). Dry adsorbed emulsion: 1 Characterization of an intricate physicochemical structure. J. Pharm. Sci. 89:991–999.
   PubMed Web of Science ®Google Scholar
• O. Chambin, V. Berard, M. H. Rochat-Gonthier, and Y. Pourcelot. (2002). Dry adsorbed emulsion: 2. Dissolution behaviour of an intricate formulation. Int. J. Pharm. 235:169–178.
   PubMed Web of Science ®Google Scholar
• K. L. Christensen, G. P. Pedersen, and H. G. Kristensen. (2001). Preparation of redispersible dry emulsion by spray drying. Int. J. Pharm. 212:187–194.
   PubMed Web of Science ®Google Scholar
• K. L. Christensen, G. P. Pedersen, and H. G. Kristensen. (2002). Physical stability of redispersible dry emulsions containing amorphous sucrose. Eur. J. Pharm. Biopharm. 53:147–153.
   PubMed Web of Science ®Google Scholar
• G. Cornaire, J. Woodley, P. Hermann, A. Cloarec, C. Arellano, and G. Houin. (2004). Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo. Int. J. Pharm. 278:119–131.
   PubMed Web of Science ®Google Scholar
• S. Corveleyn, and J. P. Remon. (1998a). Formulation of a lyophilized dry adsorbed emulsion tablet for the delivery of poorly soluble drugs. Int. J. Pharm. 166:65–74.
   Web of Science ®Google Scholar
• S. Corveleyn, and J. P. Remon. (1998b). Bioavailability of hydrochlorothiazide: Conventional versus freeze-dried tablets. Int. J. Pharm. 173:149–155.
   Web of Science ®Google Scholar
• S. Corveleyn, and J. P. Remon. (1999). Stability of freeze-dried tablets at different relative humidities. Drug Dev. Ind. Pharm. 25:1005–1013.
   PubMed Web of Science ®Google Scholar
• F. Cui, Y. Wang, J. Wang, L. Feng, and K. Ning. (2007). Preparation of redispersible dry emulsions using Eudragit E100 as both solid carrier and unique emulsifier. Coll. Surf. A: Physicochem. Eng. Asp. 307:131–141.
   Google Scholar
• H. R. Davis, K. K Pula, K. B Alton, R. E. Burrier, and R. W. Watkins. (2001). The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-Hydroxy-3-Methylglutaryl Coenzyme A reductase inhibitors in dogs. Metabolism 50:1234–1241.
   PubMed Web of Science ®Google Scholar
• G. Dollo, P. L. Corre, A. Guerin, F. O. Chevanne, J. L. Burgot, and R. Leverge. (2003). Spray-dried redispersible oil-in-water emulsion to improve oral bioavailability of poorly soluble drugs. Eur. J. Pharm. Sci. 19:273–280.
   PubMed Web of Science ®Google Scholar
• G. Dollo, P. L. Corre, F. Chevanne, and R.L. Verge. (2004). Bupivacaine containing dry adsorbed emulsion can prolong epidural anesthetic effects in rabbits. Eur. J. Pharm. Sci. 22:63–70.
   PubMed Web of Science ®Google Scholar
• N. Farah, J. Bouzan, M. Rollet, J. L. Taverdet, and J. M. Vergnaud. (1987). ‘Dry emulsion’—a sustained release form: modelling of drug transfers in liquids. Int. J. Pharm. 36:81–88.
   Google Scholar
• F. R. Formiga, I. A. A. Fonseca, K. B. Souza, A. K. A. Silva, J. P. F. Macedo, I. B. Aráujo, L. A. L. Soares, E. Socrates, and T. Egito. (2007). Influence of a lipophilic drug on the stability of emulsions: An important approach on the development of lipidic carriers. Int. J. Pharm. 344:158–160.
   PubMed Web of Science ®Google Scholar
• T. Hansen, P. Holm, and K. Schultz. (2004). Process characteristics and compaction of spray-dried emulsions containing a drug dissolved in lipid. Int. J. Pharm. 287:55–66.
   PubMed Web of Science ®Google Scholar
• T. Hansen, P. Holm, M. Rohde, and K. Schultz. (2005). In vivo evaluation of tablets and capsules containing spray-dried o/w emulsions for oral delivery of poorly soluble drugs. Int. J. Pharm. 293:203–211.
   PubMed Web of Science ®Google Scholar
• D. J. Hauss. (2007). Oral lipid based formulations. Adv. Drug Del. Rev. 59:667–676.
   PubMed Web of Science ®Google Scholar
• K. Heinzelmann, and K. Franke. (1999). Using freezing and drying techniques of emulsions for the microencapsulation of fish oil to improve oxidation stability. Colloids Surf. B. 12:223–229.
   Web of Science ®Google Scholar
• A. J. Humberstone, and W. N. Charman. (1997). Lipid- based vehicles for the oral delivery of poorly water soluble drugs. Adv. Drug Del. Rev. 25:103–128.
   Web of Science ®Google Scholar
• D. J. Jang, E. J. Jeong, H.M. Lee, B.C. Kim, S. J. Lim, and C. K. Kim. (2006). Improvement of bioavailability and photostability of amlodipine using redispersible dry emulsion. Eur. J. Pharm. Sci. 28:405–411.
   PubMed Web of Science ®Google Scholar
• B. K. Kang, J. S. Lee, S. K. Chon, S. Y. Jeong, S. H. Yuk, G. Khang, H. B. Lee, and S. H. Cho. (2004). Development of self microemulsifying drug delivery system (SMEDDS) for oral bioavailability enhancement of Simvastatin in beagle dogs. Int. J. Pharm. 274:65–73.
   PubMed Web of Science ®Google Scholar
• T. Kosoglou, P. Statkevich, A.O. Johnson-Levonos, J. F. Paolini, A. J. Bergman, and K. B. Alton. (2005). Ezetimibe: A review of its metabolism, pharmacokinetics and drug interaction. Clin. Pharmaco. 44:467–494.
   Google Scholar
• J. M. McKenney, P. H. Jones, H. E. Bays, R. H. Knopp, M. L. Kashyap, G. E. Ruoff, and M. E. McGovern. (2007). Comparative effects on lipid levels of combination therapy with a statin and extended-release niacin or ezetimibe versus a statin alone (the COMPELL study). Atherosclerosis 192:432–437.
   PubMed Web of Science ®Google Scholar
• S. L. Myers, and M. L. Shively. (1993). Solid state emulsion: the effect of maltodextrin on microcrystalline aging. Pharm. Res. 10:1389–1391.
   PubMed Web of Science ®Google Scholar
• S. Nazzal, I. I. Smalyukh, O.D. Lavrentovich, and M. A. Khan. (2002). Preparation and in vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: Mechanism and progress of emulsion formation. Int. J. Pharm. 235:247–265.
   PubMed Web of Science ®Google Scholar
• M. Newton, J. Petersson, F. Podczeck, A. Clarke, and S. Booth. (2001). The influence of formulation variables on the properties of pellets containing a self-emulsifying mixture. J. Pharm. Sci. 90:987–995.
   PubMed Web of Science ®Google Scholar
• P. Patil, V. Patil, and A. Paradkar. (2007). Formulation of a self-emulsifying system for oral delivery of simvastatin: In vitro and in vivo evaluation. Acta Pharm. 57:111–122.
   PubMedGoogle Scholar
• G. P. Pedersen, P. Faldt, B. Bergenstahl, and H. G. Kristensen. (1998). Solid state characterizations of a dry emulsion: a potential drug delivery system. Int. J. Pharm. 171:257–270.
   Google Scholar
• E. Toorisaka, M. Hashida, N. Kamiya, H Ono, Y. Kokazu, and M. Goto. (2005). An enteric-coated dry emulsion formulation for oral insulin delivery. J. Cont. Rel. 107:91–96.
   PubMed Web of Science ®Google Scholar
• C. Wandel, R.B. Kim, and M. Stein. (2003). “Inactive” excipients such as Cremophor can affect in vivo drug disposition. Clin. Pharmacol. Ther. 73:394–396.
   PubMed Web of Science ®Google Scholar